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ABSTRACT 
Motivation: The development of antibiotic resistance is one of the mechanism used to study adaptive evolution. Antibiotics not 
only select for preexisting resistant strains in a population, but they can also promote the appearance of resistant strains (1, 2). 
Antibiotics at high concentrations can be lethal to bacteria, but it has been shown that sub-inhibitory concentrations of some 
antibiotics can stimulate horizontal transfer of DNA and mutation in different chromosomal loci (1, 3). These antibiotics can 
increase the mutation rate through several mechanisms, such as oxidative stress and the SOS response, which is triggered by 
DNA damage (2, 3). In this context, we wanted to determine if commonly-used disinfectants also promote mutation.   
Methods: The disinfectants used were ethanol, sodium hypochlorite, chlorhexidine, silver nitrate, benzalkonium chloride, 
triclosan and povidone-iodine complex. The E.coli strain used was IBDS1, which includes a tetracycline gene regulated by the 
cI (Ind-) repressor gene, that allows us to measure the mutation rate. 
To study the effect of these disinfectants, the strain IBDS1 was tested with a window of concentrations very close to the 
minimum inhibitory concentration (MIC) by evaluating the appearance of mutants resistant to rifampicin or tetracycline (3). To 
determine if this effect could be linked to the induction of the SOS system, we used a plasmid which expresses the "Green 
Fluorescence Protein" (GFP) under the control of the promoter of the recA gene to detect when the SOS system is activated 
by measuring fluorescence. 
Results: Three of the disinfectants tested increased mutation frequency. Concentrations of 0.013 μg/ml and 0.026 μg/ml of 
NaClO (1/4x CMI y 1/2x MIC) increased the mutation frequency approximatly 4 fold and 0.5 μg/ml of clorhexidine (1/4x MIC) 
and 0.125 μg/ml of triclosan (1/4x MIC) 3 fold, approximately. In relation to the SOS system, none of the concentrations tested 
induced the SOS response.   
Conclusions: These results show that certain concentrations of sodium hypochlorite, chlorhexidine and triclosan increase the 
mutation frequency and therefore may facilitate the appearance of resistant strains, although it appears that this mutagenic 
effect is not related to the induction of the SOS system. Therefore, it would be interesting to study whether this mutagenic 
effects is due to the reactive oxygen species (ROS) produced by disinfectants.  
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